These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10560740)

  • 1. The inhibition of human cytomegalovirus (hCMV) protease by hydroxylamine derivatives.
    Smith DG; Gribble AD; Haigh D; Ife RJ; Lavery P; Skett P; Slingsby BP; Stacey R; Ward RW; West A
    Bioorg Med Chem Lett; 1999 Nov; 9(21):3137-42. PubMed ID: 10560740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro proteolytic activity and active-site identification of the human cytomegalovirus protease.
    Stevens JT; Mapelli C; Tsao J; Hail M; O'Boyle D; Weinheimer SP; Diianni CL
    Eur J Biochem; 1994 Dec; 226(2):361-7. PubMed ID: 8001553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metal mediated protease inhibition: design and synthesis of inhibitors of the human cytomegalovirus (hCMV) protease.
    Dhanak D; Burton G; Christmann LT; Darcy MG; Elrod KC; Kaura A; Keenan RM; Link JO; Peishoff CE; Shah DH
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2279-82. PubMed ID: 11055338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human cytomegalovirus proteinase by salcomine derivatives.
    Watanabe S; Konno K; Shigeta S; Yokota T
    Antivir Chem Chemother; 1998 May; 9(3):269-74. PubMed ID: 9875406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-chloro-3-substituted-1,4-naphthoquinone inactivators of human cytomegalovirus protease.
    Ertl P; Cooper D; Allen G; Slater MJ
    Bioorg Med Chem Lett; 1999 Oct; 9(19):2863-6. PubMed ID: 10522707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta-Lactam derivatives as inhibitors of human cytomegalovirus protease.
    Yoakim C; Ogilvie WW; Cameron DR; Chabot C; Guse I; Haché B; Naud J; O'Meara JA; Plante R; Déziel R
    J Med Chem; 1998 Jul; 41(15):2882-91. PubMed ID: 9667976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biotinylated isocoumarins, new inhibitors and reagents for detection, localization, and isolation of serine proteases.
    Kam CM; Abuelyaman AS; Li Z; Hudig D; Powers JC
    Bioconjug Chem; 1993; 4(6):560-7. PubMed ID: 8305526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the covalent modification of the catalytic triad of human cytomegalovirus protease by pseudo-reversible beta-lactam inhibitors and a peptide chloromethylketone.
    Haley TM; Angier SJ; Borthwick AD; Montgomery DS; Purvis IJ; Smart DH; Bessant C; Van Wely C; Hart GJ
    J Mass Spectrom; 1998 Dec; 33(12):1246-55. PubMed ID: 9875526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzothiopyran-4-one based reversible inhibitors of the human cytomegalovirus (HCMV) protease.
    Dhanak D; Keenan RM; Burton G; Kaura A; Darcy MG; Shah DH; Ridgers LH; Breen A; Lavery P; Tew DG; West A
    Bioorg Med Chem Lett; 1998 Dec; 8(24):3677-82. PubMed ID: 9934494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of proteases with enkephalin-analogue inhibitors.
    Demuth HU; Silberring J; Nyberg F
    J Enzyme Inhib; 1991; 4(4):289-98. PubMed ID: 1669830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective nonpeptidic inhibitors of herpes simplex virus type 1 and human cytomegalovirus proteases.
    Matsumoto M; Misawa S; Chiba N; Takaku H; Hayashi H
    Biol Pharm Bull; 2001 Mar; 24(3):236-41. PubMed ID: 11256477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-peptide inhibitors of HCV serine proteinase.
    Kakiuchi N; Komoda Y; Komoda K; Takeshita N; Okada S; Tani T; Shimotohno K
    FEBS Lett; 1998 Jan; 421(3):217-20. PubMed ID: 9468309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent and selective inactivation of proteinases with N-peptidyl-O-acylhydroxylamines.
    Demuth HU; Schönlein C; Barth A
    Biochim Biophys Acta; 1989 Jun; 996(1-2):19-22. PubMed ID: 2660912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent beta-lactam inhibitors of human cytomegalovirus protease.
    Yoakim C; Ogilvie WW; Cameron DR; Chabot C; Grand-Maître C; Guse I; Haché B; Kawai S; Naud J; O'Meara JA; Plante R; Déziel R
    Antivir Chem Chemother; 1998 Sep; 9(5):379-87. PubMed ID: 9875391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of translactam HCMV protease inhibitors as potent antivirals.
    Borthwick AD
    Med Res Rev; 2005 Jul; 25(4):427-52. PubMed ID: 15789440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conserved mode of peptidomimetic inhibition and substrate recognition of human cytomegalovirus protease.
    Tong L; Qian C; Massariol MJ; Déziel R; Yoakim C; Lagacé L
    Nat Struct Biol; 1998 Sep; 5(9):819-26. PubMed ID: 9731777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpesvirus proteases: targets for novel antiviral drugs.
    Holwerda BC
    Antiviral Res; 1997 Jun; 35(1):1-21. PubMed ID: 9224957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human cytomegalovirus UL80 protease by specific intramolecular disulfide bond formation.
    Baum EZ; Siegel MM; Bebernitz GA; Hulmes JD; Sridharan L; Sun L; Tabei K; Johnston SH; Wildey MJ; Nygaard J; Jones TR; Gluzman Y
    Biochemistry; 1996 May; 35(18):5838-46. PubMed ID: 8639545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of human cytomegalovirus (HCMV) protease sequences among laboratory strains and seven clinical isolates.
    Huffaker TK; Binford S; Patick AK; Pinko C; Kan CC; Zalman LS
    Antiviral Res; 1997 Feb; 33(3):215-8. PubMed ID: 9037377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating the role of histidine 157 in the catalytic activity of human cytomegalovirus protease.
    Khayat R; Batra R; Massariol MJ; Lagacé L; Tong L
    Biochemistry; 2001 May; 40(21):6344-51. PubMed ID: 11371196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.